BRIEF-Eleven Biotherapeutics completes exclusive licensing deal

* Completes exclusive licensing deal for IL-6 antagonist antibody technology, including EBI-031
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.